Publications

Zhao, F, Evans, K, Xiao, C, Holtzhausen, A, and Hanks, BA. "The Wnt5a-β-catenin Pathway Triggers a Metabolic Switch That Drives Indoleamine 2,3-dioxygenase Activity and Dendritic Cell Tolerization in the Melanoma Microenvironment." Society for Immunotherapy of Cancer 2016 Annual Meeting. National Harbor, Washington, DC. November 9, 2016 - November 13, 2016. BioMed Central.

Scholars@Duke

Force, JM, Briggs, A, Lowe, K, Lifshits, E, Foklman, J, and Heymach, JV. "The Differential Regulation of Taxane Sensitivity by Hypoxia in Endothelial and Lung Carcinoma Cells." Proc Am Asso Cancer Res Special Conf: Mol Path Lung Canc 2005. 2005 - 2005.

Scholars@Duke

Hanks, BA. "Utilizing Pre-Clinical Melanoma Models to Design Rational Combinatorial Immunotherapy Regimens : Lessons Learned from Targeting the TGF-beta Signaling Pathway." 2017 Melanoma Research Alliance Annual Meeting. Washington, DC. February 13, 2017 - February 15, 2017.

Scholars@Duke

Berlin, JD, Feng, Y, Catalano, P, Abbruzzese, JL, Philip, PA, McWilliams, RR, Lowy, AM, Benson III, AB, and Blackstock, AW. "An Intergroup Randomized Phase II Study of Bevacizumab or Cetuximab in Combination with Gemcitabine and in Combination with Chemoradiation in Patients with Resected Pancreatic Carcinoma: A Trial of the ECOG-ACRIN Cancer Research Group (E2204) (Published online)." Oncology.

Full Text

Force, JM, Heymach, JV, Beaudry, B, Norden-Zfoni, A, Prox, D, Briggs, A, Naumov, G, Baker, CH, Ryan, A, Folkman, J, and Johnson, BE. "Circulating Endothelial Cells as a Marker of Antiangiogenic Activity." Lung Spore Annual Meeting. 2005 - 2005.

Scholars@Duke

Force, JM, Heymach, JV, Beaudry, B, Wang, AC, Baker, C, Ryan, A, Folkman, J, and Soker, S. "Effects of the VEGFR-2 Tyrosine Kinase Inhibitor ZD6474 and Docetaxel on Circulating Endothelial Cells (CEC): Implications for Use as a Surrogate Marker." Proc AACR/NCI/EORTC Mol Targ and Canc Therapeutics. 2003 - 2003.

Scholars@Duke

Force, JM, Heymach, JV, Kulke, MH, Fuchs, CS, Connors, S, Sidor, C, George, D, Eder, JP, Folkman, J, and Soker, S. "Circulating Endothelial Cells as a Surrogate Marker of Antiangiogenic Activity in Patients Treated with Endostatin." Proc Am Soc Clin Oncol. 2003 - 2003.

Scholars@Duke

Pages